These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 26448577)

  • 1. Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up.
    Nakatani S; Sotomi Y; Ishibashi Y; Grundeken MJ; Tateishi H; Tenekecioglu E; Zeng Y; Suwannasom P; Regar E; Radu MD; Räber L; Bezerra H; Costa MA; Fitzgerald P; Prati F; Costa RA; Dijkstra J; Kimura T; Kozuma K; Tanabe K; Akasaka T; Di Mario C; Serruys PW; Onuma Y
    EuroIntervention; 2016 Dec; 12(12):1498-1509. PubMed ID: 26448577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images.
    Amrute JM; Athanasiou LS; Rikhtegar F; de la Torre Hernández JM; Camarero TG; Edelman ER
    J Biomed Opt; 2018 Mar; 23(3):1-14. PubMed ID: 29560624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unpredictable resorption of bioresorbable scaffolds-A tale of two ABSORBs.
    Pradhan A; Roy S; Bhandari M; Vishwakarma P; Perrone MA; Sethi R; Hasibuzzaman MA
    Clin Case Rep; 2024 Jun; 12(6):e9010. PubMed ID: 38827947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiopaque Fully Degradable Nanocomposites for Coronary Stents.
    Ang HY; Toong D; Chow WS; Seisilya W; Wu W; Wong P; Venkatraman SS; Foin N; Huang Y
    Sci Rep; 2018 Nov; 8(1):17409. PubMed ID: 30479353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of
    Milosevic M; Anic M; Nikolic D; Geroski V; Milicevic B; Kojic M; Filipovic N
    Front Med Technol; 2021; 3():724062. PubMed ID: 35047953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.
    Ellis SG; Kereiakes DJ; Metzger DC; Caputo RP; Rizik DG; Teirstein PS; Litt MR; Kini A; Kabour A; Marx SO; Popma JJ; McGreevy R; Zhang Z; Simonton C; Stone GW;
    N Engl J Med; 2015 Nov; 373(20):1905-15. PubMed ID: 26457558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.
    Gao R; Yang Y; Han Y; Huo Y; Chen J; Yu B; Su X; Li L; Kuo HC; Ying SW; Cheong WF; Zhang Y; Su X; Xu B; Popma JJ; Stone GW;
    J Am Coll Cardiol; 2015 Dec; 66(21):2298-2309. PubMed ID: 26471805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.
    Räber L; Brugaletta S; Yamaji K; O'Sullivan CJ; Otsuki S; Koppara T; Taniwaki M; Onuma Y; Freixa X; Eberli FR; Serruys PW; Joner M; Sabaté M; Windecker S
    J Am Coll Cardiol; 2015 Oct; 66(17):1901-14. PubMed ID: 26493663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.
    Haude M; Ince H; Abizaid A; Toelg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Neumann FJ; Kaiser C; Eeckhout E; Lim ST; Escaned J; Garcia-Garcia HM; Waksman R
    Lancet; 2016 Jan; 387(10013):31-9. PubMed ID: 26470647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioresorbable Vascular Scaffolds--Will Promise Become Reality?
    Byrne RA
    N Engl J Med; 2015 Nov; 373(20):1969-71. PubMed ID: 26457446
    [No Abstract]   [Full Text] [Related]  

  • 11. Edge Vascular Response After Resorption of the Everolimus-Eluting Bioresorbable Vascular Scaffold　- A 5-Year Serial Optical Coherence Tomography Study.
    Tateishi H; Suwannasom P; Sotomi Y; Nakatani S; Ishibashi Y; Tenekecioglu E; Abdelghani M; Cavalcante R; Zeng Y; Grundeken MJ; Albuquerque FN; Veldhof S; Onuma Y; Serruys PW;
    Circ J; 2016 Apr; 80(5):1131-41. PubMed ID: 26936236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation.
    Fabris E; Kilic ID; Caiazzo G; Serdoz R; Foin N; Sinagra G; Di Mario C
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e132-e135. PubMed ID: 26599682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-Month Outcomes With a Bioresorbable Everolimus-Eluting Scaffold: Results of the ESHC-BVS Registry at Two Australian Centers.
    Robaei D; Back L; Ooi SY; Pitney M; Jepson N
    J Invasive Cardiol; 2016 Aug; 28(8):316-22. PubMed ID: 26567454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms.
    Gori T; Jansen T; Weissner M; Foin N; Wenzel P; Schulz E; Cook S; Münzel T
    Eur Heart J; 2016 Jul; 37(26):2040-9. PubMed ID: 26543048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra- and interobserver reliability and intra-catheter reproducibility using frequency domain optical coherence tomography for the evaluation of morphometric stent parameters and qualitative assessment of stent strut coverage.
    Antonsen L; Thayssen P; Junker A; Veien KT; Hansen HS; Hansen KN; Hougaard M; Jensen LO
    Cardiovasc Revasc Med; 2015 Dec; 16(8):469-77. PubMed ID: 26475731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year clinical outcome in patients with small coronary artery disease treated with everolimus- versus paclitaxel-eluting stenting.
    Nasu K; Oikawa Y; Shirai S; Hozawa H; Kashima Y; Tohara S; Kadotani M; Gotoh R; Ujiie Y; Tanabe M; Abe H; Okamura A; Tsuji T; Suzuki M; Takeda Y; Mibiki Y; Ota H; Usui S; Nakagawa Y; Kawaguchi R; Yamashita J; Serikawa T; Aizawa T; Suzuki T;
    J Cardiol; 2016 Sep; 68(3):209-14. PubMed ID: 26454428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replicating Patient-Specific Severe Aortic Valve Stenosis With Functional 3D Modeling.
    Maragiannis D; Jackson MS; Igo SR; Schutt RC; Connell P; Grande-Allen J; Barker CM; Chang SM; Reardon MJ; Zoghbi WA; Little SH
    Circ Cardiovasc Imaging; 2015 Oct; 8(10):e003626. PubMed ID: 26450122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter anastomosis connector system for vascular access graft placement: results from a first-in-human pilot study.
    Ebner A; Ross JR; Setum CM; Kallok MJ; Yevzlin AS
    J Vasc Access; 2016; 17(2):111-7. PubMed ID: 26450084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies.
    Teuteberg JJ; Slaughter MS; Rogers JG; McGee EC; Pagani FD; Gordon R; Rame E; Acker M; Kormos RL; Salerno C; Schleeter TP; Goldstein DJ; Shin J; Starling RC; Wozniak T; Malik AS; Silvestry S; Ewald GA; Jorde UP; Naka Y; Birks E; Najarian KB; Hathaway DR; Aaronson KD;
    JACC Heart Fail; 2015 Oct; 3(10):818-28. PubMed ID: 26450000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography-guided coronary stent implantation compared to angiography: a multicentre randomised trial in PCI - design and rationale of ILUMIEN IV: OPTIMAL PCI.
    Ali Z; Landmesser U; Karimi Galougahi K; Maehara A; Matsumura M; Shlofmitz RA; Guagliumi G; Price MJ; Hill JM; Akasaka T; Prati F; Bezerra HG; Wijns W; Mintz GS; Ben-Yehuda O; McGreevy RJ; Zhang Z; Rapoza RR; West NEJ; Stone GW
    EuroIntervention; 2021 Jan; 16(13):1092-1099. PubMed ID: 32863246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.